LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma
J. Lin, L.-L. Nong, M.-Q. Li, F.-C. Yang, S.-H. Wang, M.-J. Liu Department of Pathology, Affiliated Hospital of Guilin Medical University, Guilin, China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma, by J. Lin, L.-L. Nong, M.-Q. Li, F.-C. Yang, S.-H. Wang, M.-J. Liu, published in Eur Rev Med Pharmacol Sci 2019; 23 (11): 4673-4679–DOI: 10.26355/eurrev_201906_18047–PMID: 31210293” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/18047
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
J. Lin, L.-L. Nong, M.-Q. Li, F.-C. Yang, S.-H. Wang, M.-J. Liu
LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 22
Pages: 11467-11467
DOI: 10.26355/eurrev_202011_23757